文献速递心外重症与机械循环支持

标准化方案预测左心室辅助装置成功撤除的经验

Experience with a standardized protocol to predict successful explantation of left ventricular assist devices.
PubMed 文献 · J Thorac Cardiovasc Surg · 2021-01-09

该回顾性研究分析了2016年1月至2020年3月按标准化方案评估左心室辅助装置撤除的患者。544例筛查患者中21例(3.9%)最终撤除,撤除后1年生存率95.2%,随访中多数患者心功能NYHA 1-2级。非缺血性心肌病更常见于撤除患者(20/21,P=.020)。

要点

  • 标准化方案包括超声心动图(基线、最小净流量、泵停止)及右心导管(泵停止+球囊封堵流出道)。
  • 肺毛细血管楔压<16 mm Hg者可行撤除。
  • 撤除后1年生存率95.2%,随访中61.9%为NYHA 1级。

核心结论

  • 按标准化方案评估左心室辅助装置撤除,不良事件率低,全部标准满足时撤除安全且生存和功能分级优异。

研究设计与样本

  • 回顾性分析2016年1月至2020年3月按标准化方案评估左心室辅助装置撤除的患者,共筛查544例,57例(10.5%)接受73次超声心动图检查,46例接受泵停止及球囊封堵流出道操作,21例(3.9%)最终撤除。

主要发现

  • 撤除患者基线左心室射血分数55.5%±6.5%,泵停止及球囊封堵流出道时平均肺毛细血管楔压从8.1±2.6 mm Hg升至10.7±2.9 mm Hg。
  • 撤除患者中非缺血性心肌病更常见(20/21例[95%],P=.020)。
  • 撤除后1年生存率95.2%,1例死亡发生于撤除后222天;随访中位24.9个月(四分位距16.4-43.1个月)时,NYHA 1级占61.9%,2级占28.6%,3级占9.5%。

关键数值与推荐

  • 超声心动图在「基线」「最小净流量」「泵停止」条件下进行,符合方案标准者行右心导管及泵停止+球囊封堵流出道。
  • 肺毛细血管楔压小于16 mm Hg者在「泵停止」条件下行撤除。

临床怎么用

  • 对连续流左心室辅助装置患者可按标准化方案评估心肌功能恢复,满足全部标准时行撤除,围术期不良事件少且预后良好。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Patients with a continuous-flow left ventricular assist device may show recovery of myocardial function with unloading. Identifying candidates for and predicting clinical and hemodynamic stability after left ventricular assist device explantation remain challenging. METHODS: Retrospective analysis of patients who underwent evaluation for left ventricular assist device explantation following a standardized protocol from January 2016 to March 2020. Patients who met screening criteria underwent echocardiography under "baseline," "minimal net flow," and "pump stop" conditions. If the protocol criteria were met, right heart catheterization with left ventricular assist device stoppage and occlusion of the outflow graft with a balloon catheter were performed. In patients with pulmonary capillary wedge pressure less than 16 mm Hg, explantation was performed under "pump stop" conditions. RESULTS: A total of 544 patients were screened. Of these, 57 (10.5%) underwent a total of 73 echocardiography under "baseline" "minimal net flow" and "pump stop" conditions and 46 underwent left ventricular assist device stoppage and occlusion of the outflow graft with balloon catheter maneuvers. Complications during the procedure were rare. Ultimately, 21 patients (3.9%) underwent explantation. The left ventricular ejection fraction at baseline was 55.5% ± 6.5%. The mean pulmonary capillary wedge pressure was 8.1 ± 2.6 mm Hg and increased to 10.7 ± 2.9 mm Hg under left ventricular assist device stoppage and occlusion of the outflow graft with a balloon catheter. A nonischemic cause of cardiomyopathy was more likely to be found in patients who underwent explantation (20/21 patients [95%], P = .020). The survival 1 year after explantation was 95.2%, with 1 death occurring 222 days after left ventricular assist device explantation. At follow-up (median 24.9 months [interquartile range, 16.4-43.1 months]), patients were in New York Heart Association class 1 (61.9%), 2 (28.6%), and 3 (9.5%). CONCLUSIONS: Our 4-year experience with a standardized protocol for left ventricular assist device explantation showed a low rate of adverse events. If all criteria are met, explantation can be performed safely and with an excellent survival and functional class.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Hrytsyna Y, Kneissler S, Kaufmann F, et al. Experience with a standardized protocol to predict successful explantation of left ventricular assist devices. J Thorac Cardiovasc Surg. 2021. PMID: 33581897. doi:10.1016/j.jtcvs.2021.01.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。